Skip to content

MoonLake Immunotherapeutics MLTX Accrued Income Taxes, Current

Accrued Income Taxes, Current at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.09B-74.2%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.49B-45.9%
Enterprise value$1.29B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's accrued income taxes, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's accrued income taxes, current?
MoonLake Immunotherapeutics (MLTX) reported accrued income taxes, current of $1.4M in Q1 2026.
How has MoonLake Immunotherapeutics's accrued income taxes, current changed year-over-year?
MoonLake Immunotherapeutics's accrued income taxes, current decreased by 37.5% year-over-year, from $2.23M to $1.4M.
What is the long-term trend for MoonLake Immunotherapeutics's accrued income taxes, current?
Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's accrued income taxes, current has grown at a 103.4% compound annual growth rate (CAGR), from $63.92K to $1.09M.
What does accrued income taxes, current mean?
This represents the estimated amount of income tax payable to government authorities for the current period. It reflects the company's tax liability based on taxable income generated during the year, which is due within the next twelve months. It is a key indicator of the company's immediate tax obligations.